Supreme Court Deadlock Lets Rezulin Case Advance

Law360, New York (March 3, 2008, 12:00 AM EST) -- In a 4-4 split, the U.S. Supreme Court has affirmed a lower court's ruling in a battle between Pfizer Inc.'s Warner-Lambert unit and a group of Michigan patients, effectively allowing the Michigan residents to advance their claims against Pfizer over the diabetes drug Rezulin.

Handing down a two-sentence decision just one week after oral arguments, the justices did little to resolve a conflict between lower courts over whether the U.S. Food and Drug Administration's regulations shield a pharmaceutical company from consumers' claims that the company defrauded...
To view the full article, register now.